Interpretation Pitfalls of HbA1c and Use of Alternative Glycemic Markers
1. Conditions That Shorten Red‑Blood‑Cell Survival → Falsely Low HbA1c
- Hemolytic anemia, recent acute blood loss, chronic renal failure/hemodialysis, and anemia from hematologic malignancies (Hb < 10 g/dL) each produce HbA1c values ≈0.8–0.9 % lower than expected, leading to underestimation of true glycemic exposure. 1
- In these settings, clinicians should rely on direct glucose measurements or alternative glycated proteins (fructosamine, glycated albumin) rather than HbA1c for monitoring. 1
2. Conditions That Increase HbA1c → Risk of Overdiagnosis
- Iron‑deficiency anemia raises HbA1c independent of glucose levels, potentially causing false‑positive diabetes diagnoses. 1
- Normal inter‑individual variation in red‑cell lifespan (48–68 days) can create discordance between average glucose and HbA1c, contributing to misclassification. 1
3. Hemoglobin Variants and Assay Interference
- Homozygous hemoglobin variants lacking HbA (e.g., HbSS, HbEE) render HbA1c measurement impossible; fructosamine or glycated albumin must be used instead. 1
- Heterozygous hemoglobin variants may cause assay‑specific bias; laboratories should select HbA1c methods that are validated for the prevalent variants in their patient population. 1
4. Physiologic Demographic Influences
- In adults without diabetes, HbA1c rises ~0.1 % per decade after age 30, even after excluding undiagnosed diabetes or impaired glucose tolerance. 1
- Racial background does not modify the relationship between HbA1c levels and adverse cardiovascular outcomes or mortality. 1
5. Biochemical and Medication Interferences
- High‑dose vitamin C or vitamin E can artificially lower HbA1c by inhibiting hemoglobin glycation. 1
- Historical interferences from hypertriglyceridemia, hyperbilirubinemia, uremia, chronic alcoholism, salicylates, and opiate use are generally not observed with contemporary HbA1c assay technologies. 1
6. Pregnancy‑Specific Considerations
- Accelerated red‑cell turnover in pregnancy lowers HbA1c values, making standard reference ranges inappropriate for pregnant women without diabetes. 1
- In pregnant patients with pre‑existing diabetes, maintaining HbA1c < 6 % (when achievable without significant hypoglycemia) reduces the risk of congenital malformations and other pregnancy complications. 1
7. Pre‑analytical Sample Handling (Praxis Medical Insights)
| Condition | Recommended Practice | Evidence |
|---|---|---|
| Storage temperature > 30 °C | Avoid; leads to significant analytical error | 2 |
| Refrigerated storage (4 °C) | Stable for up to 7 days | 2 |
| Long‑term storage | Freeze at ≤ ‑70 °C; ‑20 °C is insufficient | 2 |
| Anticoagulant | Use EDTA unless manufacturer specifies otherwise; EDTA does not interfere with HbA1c assays | 2 |
8. Alternative Glycemic Markers When HbA1c Is Unreliable
- Fructosamine and glycated albumin assays provide reliable estimates of average glycemia over a shorter interval (2–3 weeks) and should be employed when red‑cell turnover abnormalities, hemoglobin variants, or assay interferences compromise HbA1c interpretation. 1